Clinical Study of mRNA Vaccine in Patients With Liver Cancer After Operation

NCT05761717 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Posto Perative Hepatocellular Carcinoma

Interventions

DRUG: Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I njection

Sponsor

Shanghai Zhongshan Hospital